Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 6/20 | 0.66 |
| ▸ | MEN1 | O00255 | 6/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.66 |
| ▸ | MAPT | P10636 | 5/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.66 |
| ▸ | HTT | P42858 | 2/20 | 0.66 |
| ▸ | RECQL | P46063 | 2/20 | 0.66 |
| ▸ | BLM | P54132 | 2/20 | 0.66 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.66 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.66 |
| ▸ | HPGD | P15428 | 1/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.66 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 3/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 5/20 | 0.56 |
| ▸ | USP2 | O75604 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.48 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8918610 | 0.97 | FTO (0.69) | FTOMEN1KMT2AMAPTTDP1 | |
| SCHEMBL9903928 | 0.91 | MEN1 (0.58) | FTOMEN1KMT2AMAPTTDP1 | |
| SCHEMBL6405766 | 0.91 | FTO (0.61) | FTOMEN1KMT2AMAPTTDP1 | |
| SCHEMBL9105623 | 0.90 | FTO (0.57) | FTOMEN1KMT2AMAPTTDP1 | |
| SCHEMBL12203251 | 0.89 | FTO (0.85) | FTOMEN1KMT2AMAPTTDP1 | |
| SCHEMBL14415063 | 0.89 | FTO (0.60) | FTOMEN1KMT2AMAPTTDP1 | |
| SCHEMBL6410494 | 0.88 | FTO (0.59) | FTOMEN1KMT2AMAPTTDP1 | |
| SCHEMBL29486497 | 0.86 | MAPT (0.69) | FTOMEN1KMT2AMAPTTDP1 | |
| SCHEMBL29474194 | 0.86 | MAPT (0.69) | FTOMEN1KMT2AMAPTTDP1 | |
| SCHEMBL77954 | 0.86 | MAPT (0.69) | FTOMEN1KMT2AMAPTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10400263-B2 | Tripeptide rhodamine compound | KINGSTON UNIVERSITY HIGHER EDUCATION CORPORATION (GB) | 2019-09-03 | — | — | US | disclosed |
| US-20170073537-A1 | SYSTEM AND METHOD FOR APPLICATION OF CHROMIC COMPOSITIONS | JPMORGAN CHASE BANK, N.A. | 2017-03-16 | — | — | US | disclosed |
| US-20150240283-A1 | Compound | Kingston Universty Higher Education Corporation (GB) | 2015-08-27 | — | — | US | disclosed |
| US-20150240283-A1 | Compound | Kingston Universty Higher Education Corporation (GB) | 2015-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10400263-B2 | Tripeptide rhodamine compound | RNPEP, PEPD, DNPEP | FTO 4360/4885MEN1 3879/4885KMT2A 2003/4885 |
| US-20150240283-A1 | Compound | RPIA, STS, CLPP | FTO 3470/4885MEN1 4222/4885KMT2A 911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.